The Abraaj Capital group is a leading private equity manager investing in the rapidly growing economies of the Middle East, Africa, Turkey and Asia. Since inception in 2002, it has raised over US$ 7 billion and distributed around US$ 3 billion to investors. Headquartered in Dubai, the Abraaj Capital group employs over 150 people and has a presence in Riyadh, Istanbul, Cairo, Singapore, Mumbai, Karachi, Beirut, Ramallah, Amman, Casablanca and Tunis. The group’s flagship private equity business has helped accelerate and facilitate the growth of over 40 companies in 12 countries in the region, in attractive and fundamental sectors such as healthcare, education, energy, aviation and logistics, to name a few.

 

The Abraaj Capital group manages eight Funds: four Private Equity Funds, Riyada Enterprise Development (a Fund dedicated to small and medium enterprises), Kantara (a Fund dedicated to small and midcap enterprises in North Africa), ASAS (an income-generating, real estate Fund) and a 2004 vintage real estate Fund. The Abraaj Capital group currently manages over US$ 6 billion of equity assets. Funds managed by the Abraaj Capital group have holdings in over 35 companies in the region, which collectively employ in excess of 30,000 people, including Air Arabia, the region’s leading low-cost carrier, Acibadem Healthcare Group (Turkey’s largest privately owned hospital operator), and Al Borg Laboratories, the Middle East’s largest privately owned medical testing laboratory business.

In 2011, Abraaj Capital was ranked the largest private equity firm in emerging markets worldwide by Private Equity International. In addition, Abraaj Capital has won many regional and international awards, including the ‘Middle Eastern Private Equity Firm of the Year’ for six consecutive years, awarded by Private Equity International.

 

Abraaj Capital Limited, a member of the Abraaj Capital group is licensed by the Dubai Financial Services Authority (DFSA).